Cisen Pharmaceutical Co., Ltd. (SHA:603367)
China · Delayed Price · Currency is CNY 14.53
+0.31 (2.18%)
Sep 30, 2026, 3:00 PM CST
Cisen Pharmaceutical Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 3,398 | 3,445 | 3,982 | 4,462 | 4,066 | 3,783 |
Revenue Growth | -6.92% | -13.48% | -10.77% | 9.74% | 7.50% | 2.95% |
Gross Profit Gross Profit Growth | 1,666 | 1,711 | 2,168 | 2,550 | 2,239 | 2,055 |
Operating Income Operating Income Growth | 225.93 | 270.96 | 444.59 | 550.79 | 291.2 | 214.24 |
Net Income Net Income Growth | 456.53 | 421.25 | 508.91 | 521.34 | 349.96 | 334.15 |
Earnings Per Share EPS Growth | 1.00 | 0.93 | 1.12 | 1.15 | 0.77 | 0.74 |
EPS Growth | -2.93% | -16.96% | -2.61% | 49.35% | 4.05% | -23.71% |
| Fiscal Year | FY 2025 |
|---|---|
| Period Ending | Dec '25 Dec 31, 2025 |
China China Growth | 3,362 |
Overseas Overseas Growth | 64.88 |
Total Total Growth | 3,427 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 4,034 | 3,406 | 2,797 | 2,775 | 2,784 | 2,424 |
Total Debt Total Debt Growth | 32.84 | 43.53 | 115.83 | 170.67 | 158.61 | 143.63 |
Net Cash (Debt) Net Cash Growth | 4,001 | 3,362 | 2,681 | 2,604 | 2,625 | 2,280 |
Net Cash Growth | 29.28% | 25.39% | 2.95% | -0.79% | 15.15% | 3.32% |
Net Cash Per Share Net Cash Per Share Growth | 8.77 | 7.42 | 5.90 | 5.75 | 5.78 | 5.05 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 540.15 | 466.37 | 570.85 | 451.24 | 258.35 | 233.6 |
Capital Expenditures CapEx Growth | -29.27 | -64.76 | -101.81 | -17.71 | -35.19 | -51.02 |
Free Cash Flow Free Cash Flow Growth | 510.88 | 401.61 | 469.04 | 433.53 | 223.15 | 182.58 |
Free Cash Flow Growth | -20.62% | -14.38% | 8.19% | 94.27% | 22.22% | -20.18% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 49.02% | 49.66% | 54.46% | 57.14% | 55.06% | 54.32% |
Operating Margin | 6.65% | 7.87% | 11.17% | 12.34% | 7.16% | 5.66% |
Pretax Margin | 15.45% | 14.40% | 14.46% | 13.35% | 9.01% | 8.89% |
Profit Margin | 13.44% | 12.23% | 12.78% | 11.68% | 8.61% | 8.83% |
FCF Margin | 15.03% | 11.66% | 11.78% | 9.71% | 5.49% | 4.83% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.320 | 0.348 | 0.440 | 0.436 | 0.335 | 0.300 |
Dividend Per Share Growth | -7.84% | -20.91% | 0.92% | 30.15% | 11.67% | 17.19% |
Dividend Yield | 2.20% | 2.07% | 3.37% | 3.28% | 3.00% | 2.60% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 14.52 | 18.61 | 12.22 | 12.66 | 16.20 | 17.89 |
Forward PE | - | 46.95 | 46.95 | 46.95 | 46.95 | 46.95 |
P/FCF Ratio | 12.88 | 19.53 | 13.26 | 15.23 | 25.40 | 32.74 |
PS Ratio | 1.94 | 2.28 | 1.56 | 1.48 | 1.39 | 1.58 |